Our moon shot to curing coma will take everyone. We all need to work together toward the grand challenge of awakening hope.
Wendy Ziai, MD, MPH
Advertisement
Professor of Neurology, Johns Hopkins University; and member, Curing Coma Campaign Scientific Steering Committee, Neurocritical Care Society
Articles by Wendy Ziai, MD, MPH
The professor of neurology at Johns Hopkins University, and a member of the Curing Coma Campaign’s Scientific Steering Committee spoke to the current limitations of clinical trials in coma.
The professor of neurology at Johns Hopkins University, and a member of the Curing Coma Campaign’s Scientific Steering Committee shared her insight into the current management of coma and the need for better prognostication.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
2
Exploring Long-Term Efficacy of Inebilizumab in Phase 3 Myasthenia Gravis Trial: Richard Nowak, MD, MS
3
New Study to Assess Complement Inhibitor Iptacopan in Generalized Myasthenia Gravis
4
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
5
